Loading...

Yong-Mi Kim, MD, PhD

Title(s)Associate Professor of Pediatrics
Phone+1 323 361 8544
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Required Scholarly Project Mentor

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Poulard C, Kim HN, Fang M, Kruth K, Gagnieux C, Gerke DS, Bhojwani D, Kim YM, Kampmann M, Stallcup MR, Pufall MA. Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2019 02 19; 116(8):3052-3061. PMID: 30733284.
      View in: PubMed
    2. Sanchez VE, Nichols C, Kim HN, Gang EJ, Kim YM. Targeting PI3K Signaling in Acute Lymphoblastic Leukemia. Int J Mol Sci. 2019 Jan 18; 20(2). PMID: 30669372.
      View in: PubMed
    3. Liu HC, Gang EJ, Kim HN, Lim HG, Jung H, Chen R, Abdel-Azim H, Shung KK, Kim YM. Characterizing Deformability of Drug Resistant Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells Using Acoustic Tweezers. Sci Rep. 2018 Oct 24; 8(1):15708. PMID: 30356155.
      View in: PubMed
    4. Adam E, Kim HN, Gang EJ, Schnair C, Lee S, Lee S, Khazal S, Kosoyan O, Konopleva M, Parekh C, Bhojwani D, Wayne AS, Abdel-Azim H, Heisterkamp N, Kim YM. The PI3Kd Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL. Cancers (Basel). 2017 Sep 10; 9(9). PMID: 28891959.
      View in: PubMed
    5. Kim YM, Gang EJ, Kahn M. CBP/Catenin antagonists: Targeting LSCs' Achilles heel. Exp Hematol. 2017 08; 52:1-11. PMID: 28479420.
      View in: PubMed
    6. Duchartre Y, Kim YM, Kahn M. Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells. Methods Mol Biol. 2017; 1613:463-478. PMID: 28849572.
      View in: PubMed
    7. Li L, Qi X, Sun W, Abdel-Azim H, Lou S, Zhu H, Prasadarao NV, Zhou A, Shimada H, Shudo K, Kim YM, Khazal S, He Q, Warburton D, Wu L. Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality. EMBO Mol Med. 2016 11; 8(11):1340-1359. PMID: 27737899.
      View in: PubMed
    8. Duchartre Y, Kim YM, Kahn M. The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol. 2016 Mar; 99:141-9. PMID: 26775730.
      View in: PubMed
    9. Hsieh YT, Gang EJ, Shishido SN, Kim HN, Pham J, Khazal S, Osborne A, Esguerra ZA, Kwok E, Jang J, Bonig H, Biediger RJ, Vanderslice P, Kim YM. Effects of the small-molecule inhibitor of integrin a4, TBC3486, on pre-B-ALL cells. Leukemia. 2014 Oct; 28(10):2101-4. PMID: 24903479.
      View in: PubMed
    10. Shishido S, Bönig H, Kim YM. Role of integrin alpha4 in drug resistance of leukemia. Front Oncol. 2014; 4:99. PMID: 24904821.
      View in: PubMed
    11. Hsieh YT, Gang EJ, Geng H, Park E, Huantes S, Chudziak D, Dauber K, Schaefer P, Scharman C, Shimada H, Shojaee S, Klemm L, Parameswaran R, Loh M, Kang ES, Koo HH, Hofmann WK, Andrade J, Crooks GM, Willman CL, Müschen M, Papayannopoulou T, Heisterkamp N, Bönig H, Kim YM. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. Blood. 2013 Mar 07; 121(10):1814-8. PMID: 23319569.
      View in: PubMed
    12. Kim YM, Ma H, Oehler VG, Gang EJ, Nguyen C, Masiello D, Liu H, Zhao Y, Radich J, Kahn M. The gamma catenin/CBP complex maintains survivin transcription in ß-catenin deficient/depleted cancer cells. Curr Cancer Drug Targets. 2011 Feb; 11(2):213-25. PMID: 21158719.
      View in: PubMed